Tzu Chi General Hospital Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2007
NCT00535015
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Tzu Chi General Hospital Taipei Branch | Yao-Kuang Wu

Active Ingredients

Drugs in Phase 2 Trials (1)

piroxicam (feldene) (1 trial)

Drugs in Other Trials (1)

jing-si (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anorexia (Phase 2)

Cachexia (Phase 2)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Weight Loss (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2